Surgically induced astigmatism and refractive outcomes after minimally invasive glaucoma surgery combined with

Suguru Nakagawa1, Yoshihito Kato2, Kiyohito Totsuka2

  • 1Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-ku, Saitama, Japan. snakagawa-tky@umin.ac.jp.

Scientific Reports
|April 22, 2025
PubMed

Insights

Minimally invasive glaucoma surgery (MIGS) shows minimal surgically induced astigmatism (SIA) across iStent, iStent inject W, and microhook ab interno trabeculotomy. These MIGS procedures offer refractive stability when combined with cataract surgery.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Refractive Surgery

Background:

  • Minimally invasive glaucoma surgery (MIGS) is theorized to cause less surgically induced astigmatism (SIA) due to smaller incisions.
  • Limited research exists on SIA specifically within MIGS procedures.
  • Evaluating refractive outcomes alongside SIA is crucial for patient satisfaction.

Purpose of the Study:

  • To compare SIA and refractive outcomes among three distinct MIGS techniques.
  • To assess the refractive neutrality of MIGS procedures in various glaucoma subtypes.
  • To provide data supporting MIGS as a refractive-stable option when combined with cataract surgery.

Main Methods:

  • Retrospective cohort study comparing first-generation iStent (IS), second-generation iStent inject W (IW), and microhook ab interno trabeculotomy (μLOT).
  • Analysis included SIA, refractive prediction error (RPE), intraocular pressure (IOP) reduction, and glaucoma subtypes.
  • Statistical analysis utilized a linear mixed model to compare outcomes between the three MIGS groups.

Main Results:

  • SIA was minimal and not significantly different across the IS, IW, and μLOT groups (p=0.95).
  • Refractive prediction error differed significantly between IW and μLOT (p=0.025), but remained mild.
  • The μLOT group showed a slight myopic shift and greater IOP reduction; however, absolute prediction error did not significantly differ among groups (p=0.062).

Conclusions:

  • MIGS procedures, including IS, IW, and μLOT, demonstrate refractive stability when performed with cataract surgery.
  • These MIGS techniques are equally viable from a refractive perspective.
  • Subgroup analysis confirmed refractive neutrality across primary open-angle glaucoma, pseudoexfoliative glaucoma, and chronic angle-closure glaucoma.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
374
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
470
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
358